| Free samples of doctor-recommended MiraLAX |
|
|
| |
| |
| Did you know that MiraLAX® has a 96% patient satisfaction rate?1 |
| |
| Dear Doctor: |
| |
| It's no surprise patients are satisfied with the predictable, reliable relief that MiraLAX (PEG 3350) offers. As an OTC product with a prescription heritage, MiraLAX is clinically proven to safely and effectively relieve occasional constipation with very few side effects.2‑4 |
| |
| As an osmotic laxative, MiraLAX provides a dual beneift2‑4: |
| |
|
|
Works naturally with the water in your body to hydrate and soften stool |
| |
|
|
Relieves occasional constipation without causing gas, bloating, cramping, or sudden urgency |
| |
|
| Patients aren't the only ones who prefer* the gentle power of MiraLAX—GIs do as well. In fact, MiraLAX has been the #1 GI-recommended OTC laxative for over 10 years. |
| |
| Start with MiraLAX first—the leader in occasional constipation relief. |
|
|
|
|
| |
|
|
| |
| * |
| Among branded laxatives. |
| |
| References: 1. Survey of 672 consumers, August 2017, Bayer Consumer Health. 2. DiPalma JA, Cleveland MB, McGowan J, Herrera JL. A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications. South Med J. 2007;100(11):1085-1090. 3. DiPalma JA, DeRidder PH, Orlando RC, Kolts BE, Cleveland MB. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol. 2000;95(2):446-450. 4. DiPalma JA, Cleveland MV, McGowan J, Herrera JL. An open-label study of chronic polyethylene glycol laxative use in chronic constipation. Aliment Pharmacol Ther. 2007;25(6):703-708. |
| |
| The Bayer Cross and MiraLAX are registered trademarks of Bayer. |
| |
| © 2018 Bayer May 2018 0662-PP-MLX-BASE-US-0474 |
| |
|
|
| Unsubscribe |
| |
| Skipta, 8 North Queen Street, Suite 800, Lancaster, PA 17603 |
| |
|
|
|
|